Innovations in Cancer: Laser Light, AI, and Micromaterials

Quality of life should be the top priority for patients with late-stage cancer, but standard chemotherapy treatments often bring great physical and emotional hardship in their final months. A new platform for injectable microparticles that combine thermal ablation and targeted chemotherapy at the tumor site may help is helping to change that, as well as opening up a new approach to treat the realm of therapeutic potential for cancer treatment at earlier stages. Jim Banks looks at the pioneering work of esteemed bioengineer Dr. Ana Jaklenec, principal investigator at the David H. Koch Institute for Integrative Cancer Research at MIT.